Thermo Fisher Scientific to acquire purification & filtration business of Solventum for $4.1bn.

Thermo Fisher Scientific, a supplier of analytical instruments and life sciences solutions, agreed to acquire purification & filtration business of Solventum, a health care company, for $4.1bn. “The addition of Solventum’s business is an outstanding strategic fit with our company and will create significant value for our customers and shareholders. Solventum’s portfolio of solutions will be valued by our customers, and further demonstrate our disciplined capital deployment strategy which has an excellent track record of creating shareholder value,” Marc N. Casper, Thermo Fisher Chairman, President and CEO.